Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer : a Multicenter Non-randomized Prospective Cohort Study

NCT01460186 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT01460186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01460186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer : a Multicenter Non-randomized Prospective Cohort Study
Lead sponsor
Centre Leon Berard
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2011
Completion date
September 1, 2017
Enrollment
1,000 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastasis